The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| TNDM | +12.93% | -75.7% | -24.62% | -88% |
| S&P | +16.91% | +77.79% | +12.19% | +281% |
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
The med tech supplier is shifting to a more predictable and lucrative business model.
The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $290.38M | 2.7% |
| Gross Profit | $167.46M | 6.4% |
| Gross Margin | 57.67% | 2.0% |
| Market Cap | $1.49B | -37.0% |
| Market Cap / Employee | $596.12K | 0.0% |
| Employees | 2.5K | -5.7% |
| Net Income | -$589.00K | -178.0% |
| EBITDA | $12.79M | 249.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $90.63M | 30.9% |
| Accounts Receivable | $165.49M | 44.4% |
| Inventory | 128.8 | -13.9% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $425.00M | 2.5% |
| Short Term Debt | $24.37M | -58.6% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -22.15% | -12.1% |
| Return On Invested Capital | -12.07% | -0.5% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $3.10M | -59.4% |
| Operating Free Cash Flow | $9.79M | -8.7% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 4.83 | 7.99 | 6.15 | 11.20 | 12.63% |
| Price to Sales | 1.29 | 1.25 | 0.82 | 1.47 | -41.87% |
| Price to Tangible Book Value | 4.84 | 7.99 | 6.15 | 11.20 | 12.63% |
| Price to Free Cash Flow TTM | 477.17 | - | |||
| Enterprise Value to EBITDA | -33.78 | -50.32 | -61.11 | 129.15 | -80.44% |
| Free Cash Flow Yield | 0.2% | - | |||
| Return on Equity | -92.3% | -111.9% | -109.7% | -97.9% | 193.95% |
| Total Debt | $493.20M | $449.01M | $449.28M | $449.38M | -5.11% |
TNDM earnings call for the period ending September 30, 2021.
TNDM earnings call for the period ending June 30, 2021.
TNDM earnings call for the period ending March 31, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
